These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Immunopathology of Duhring's dermatitis herpetiformis]. Pehamberger H; Konrad K; Holubar K Hautarzt; 1979 Dec; 30(12):640-5. PubMed ID: 548520 [TBL] [Abstract][Full Text] [Related]
15. Phenol block of peripheral nerves. Moritz U Scand J Rehabil Med; 1973; 5(4):160-3. PubMed ID: 4773357 [No Abstract] [Full Text] [Related]
16. [Evaluation of sulfones in the treatment of dermatitis herpetiformis with particular reference to adverse effects]. Pawlik H; Placek W; Kwietniak K Przegl Dermatol; 1980; 67(2):221-7. PubMed ID: 6996039 [No Abstract] [Full Text] [Related]
17. Current clinical therapeutics: dermatitis herpetiformis. Millikan LE; Goldner R Int J Dermatol; 1976 Sep; 15(7):538-44. PubMed ID: 965141 [No Abstract] [Full Text] [Related]
19. [Nosologic position of the bullous variety of Duhring's dermatitis herpetiformis in the child. Histology, immunofluorescence histology and electron microscopy studies]. Brehm K; Paul E; Schmitt H Hautarzt; 1974 Aug; 25(8):379-84. PubMed ID: 4608756 [No Abstract] [Full Text] [Related]
20. [Neurotoxicity of formyl leurosine. An experimental and clinical study (author's transl)]. Hildebrand J; Joffroy A; Vauthier J; Flamant-Durand J Acta Neurol Belg; 1979; 79(4):322-34. PubMed ID: 232962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]